Results 91 to 100 of about 159,964 (350)
Biliary‐tract cancer in Chile
International Journal of Cancer, 1990 AbstractThis epidemiological study in Chile shows a marked increase in biliary‐tract cancer based on mortality data, from an age‐adjusted rate (1970 world population) of 5.1 per 100,000 in 1970 to 12.0 per 100,000 in 1988. There is an increased risk of this cancer in all age groups but especially in young adults (15‐44 years).Serra, Ivan, Calvo, Alfonso, Maturana, Mauricio, Sharp, Allan +3 moreopenaire +3 more sourcesPembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet, 2023 R. Kelley, M. Ueno, C. Yoo, Richard S. Finn, J. Furuse, Z. Ren, T. Yau, H. Klümpen, Stephen L. Chan, M. Ozaka, C. Verslype, M. Bouattour, Joon-Oh Park, O. Barajas, U. Pelzer, J. Valle, Li Yu, U. Malhotra, A. Siegel, J. Edeline, A. Vogel, M. Akce, Inmaculada Ales Diaz, G. Alves, Sumitra Anand, Ç. Arslan, J. Asselah, E. Assenat, F. Aubin, L. Bai, Y. Bai, Susan Bates, S. Begbie, I. Ben-Aharon, Nina Beri, M. Berres, J. Blanc, I. Borbath, R. Bordonaro, G. Brandi, Adam H. Burgoyne, Kritiya Butthongkomvong, M. Camandaroba, Ke Cao, M. Carballido, Stephan Lam Chan, Jen‐Shi Chen, Ming-Huang Chen, Xiaoming Chen, A. Cheng, T. Chiu, Hye Jin Choi, H. Chon, J. Collignon, A. C. Gracián, Sarah Davis, Ricardo Saraiva de Carvalho, D. J. Groot, A. Demols, J. Vos, M. Diab, J. Easaw, M. Eatock, Rawad Elias, F. Eskens, A. Falcone, P. Fernández, Richard S. Finn, F. Franke, M. Furukawa, O. Gbolahan, K. Geboes, Keri-Lee Geneser, Zhimin Geng, R. Geva, R. Gillmore, T. Goetze, H. Gou, J. Grasselli, S. Gu, M. Gumus, N. H. Mohammad, C. Hao, H. Harputluoglu, H. Hatoum, V. Heinemann, W.K. Ho, Chiun Hsu, A. Hubert, J. Hwang, M. Inanc, S. Iseas, Vaishnavi Jeyasingam, P. Fonseca, W. Joubert, J. Juengsamarn, D. Kaen, Masashi Kanai, Stefan Kasper-Virchow, G. Kazemi, F. Kelleher, R. Kelley, Jin Won Kim, Jong Gwang Kim, A. Abrahao, H. Klumpen, M. Kochenderfer, F. Kose, Ho-Ching Lam, Choong-kun Lee, Hyun Woo Lee, Margaret Lee, M. Lee, W. Lee, S. Sourd, Dongliang Li, Wei Li, Houjie Liang, T. Liang, Chun Sen Lim, B. Lingerfelt, Charles A. Lopez, J. Low, T. M. Mercade, D. Malka, Y. Mao, G. Masi, S. McCune, R. McDermott, E. Mcwhirter, G. Mendez, M. Milella, Nobumasa Mizuno, T. Mizutani, C. Moniz, Luisa Morales, A. J. M. Martín, B. Nervi, N. Ngamphaiboon, S. Oh, B. Oksuzoglu, D. Outlaw, M. Ozguroglu, O. Ozyılkan, C. Painemal, Yueyin Pan, Chuang Peng, C. Pétorin, D. Pezet, D. Power, S. Qin, A. Roohullah, Hyewon Ryu, P. Salman, Mitsuhito Sasaki, R. Sasidharan, T. Satoh, K. Schulze, M. Scott-Brown, Rubén Segovia, Thomas Seufferlein, Salvatore Siena, I. Sinapi, C. Smolenschi, T. Song, A. Sookprasert, N. Soparattanapaisarn, N. Starling, S. Stein, S. Stemmer, Haichuan Su, R. Sugimoto, T. Suksombooncharoen, V. Tam, Ai Lian Tan, C. Tan, S. Tanasanvimon, G. Tonini, G. Tortora, A. Tsuji, Rodrigo Uribe, M. Venerito, H. Mata, A. Victorino, J. Wade, D. Waldschmidt, Lulu Wang, Wan Zamaniah Wan Isahk, Harpeet Wasan, R. Weschenfelder, Chun-yin Louisa Wong, Y. F. Wong, Ş. Yalçın, P. Weber, Xuezhong Yang, H. Yasui, O. Yazıcı, C. Yen, J. Ying, Wenchang Yu, Haitao Zhao +200 moresemanticscholar +1 more sourceCombination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: The FUGA-BT (JCOG1113) Randomized Phase III Clinical Trial.
Annals of Oncology, 2019 BACKGROUND
Gemcitabine plus cisplatin (GC) is the standard treatment for advanced biliary tract cancer (BTC); however, it causes nausea, vomiting, and anorexia, and requires hydration.C. Morizane, T. Okusaka, J. Mizusawa, H. Katayama, M. Ueno, Masataka Ikeda, M. Ozaka, N. Okano, K. Sugimori, A. Fukutomi, H. Hara, N. Mizuno, H. Yanagimoto, K. Wada, K. Tobimatsu, K. Yane, S. Nakamori, H. Yamaguchi, A. Asagi, S. Yukisawa, Y. Kojima, K. Kawabe, Y. Kawamoto, R. Sugimoto, T. Iwai, Kenji Nakamura, H. Miyakawa, T. Yamashita, A. Hosokawa, T. Ioka, N. Kato, K. Shioji, K. Shimizu, T. Nakagohri, K. Kamata, H. Ishii, J. Furuse +36 moresemanticscholar +1 more sourcePreoperative Aortic Calcification Volume Predicts Postoperative Complications in Nonpancreatic Cancer Patients Undergoing Pancreaticoduodenectomy
Annals of Gastroenterological Surgery, EarlyView.ABSTRACT Background/Objectives
Postoperative complications following pancreaticoduodenectomy (PD) remain high, particularly in patients with soft pancreatic texture. Abdominal aortic calcification volume (AACV), a surrogate marker of systemic arteriosclerosis, has been associated with increased surgical risk in lower gastrointestinal procedures ...Masaki Horiuchi, Kentaro Miyake, Kota Sahara, Jun Yamamoto, Yutaro Kikuchi, Yasuhiro Yabushita, Yu Sawada, Yuki Homma, Ryusei Matsuyama, Itaru Endo +9 morewiley +1 more sourceIntegrated Multi-Omics Profiling Identifies PDZ-Binding Kinase (PBK) as a Novel Prognostic Biomarker in Hepatocellular Carcinoma
Journal of Hepatocellular CarcinomaJuan Zhang,1,* Yingyu Xu,2,* Xiaojian Ni,2,* Zhiyi Mao,3,* Haitao Xiao,4 Maopei Chen,1 Youpei Lin,5 Jiaomeng Pan,5 Boheng Zhang,6 Lan Zhang,1 Xueying Zheng,3 Guohe Song,5 Ningling Ge1 1Department of Hepatobiliary Oncology, Zhang J, Xu Y, Ni X, Mao Z, Xiao H, Chen M, Lin Y, Pan J, Zhang B, Zhang L, Zheng X, Song G, Ge N +12 moredoaj Precursors to Cholangiocarcinoma
Gastroenterology Research and Practice, 2019 Cancers of the biliary tract include intra- and extrahepatic cholangiocarcinomas and gallbladder cancer. Biliary tract cancers are diseases with unfavorable prognoses.Tomas Hucldoaj +1 more source